Lung Cancers Completed Phase 2 Trials for Temozolomide (DB00853)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00740636Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung CancerTreatment
NCT00238251Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain MetastasesTreatment
NCT00080938Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung CancerTreatment
NCT00022711Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung CancerTreatment
NCT00006877Temozolomide in Treating Patients With Metastatic Non-small Cell Lung CancerTreatment
NCT00005037Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerTreatment
NCT00003062Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung CancerTreatment